150 related articles for article (PubMed ID: 15657642)
1. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.
Rockenstein E; Adame A; Mante M; Larrea G; Crews L; Windisch M; Moessler H; Masliah E
J Neural Transm (Vienna); 2005 Feb; 112(2):269-82. PubMed ID: 15657642
[TBL] [Abstract][Full Text] [Related]
2. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
3. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
[TBL] [Abstract][Full Text] [Related]
4. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
Rockenstein E; Ubhi K; Pham E; Michael S; Doppler E; Novak P; Inglis C; Mante M; Adame A; Alvarez XA; Moessler H; Masliah E
J Neurosci Res; 2011 Nov; 89(11):1812-21. PubMed ID: 21793038
[TBL] [Abstract][Full Text] [Related]
6. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
Rockenstein E; Mallory M; Mante M; Alford M; Windisch M; Moessler H; Masliah E
J Neural Transm Suppl; 2002; (62):327-36. PubMed ID: 12456076
[TBL] [Abstract][Full Text] [Related]
7. Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
Rockenstein E; Desplats P; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
Stem Cell Res; 2015 Jul; 15(1):54-67. PubMed ID: 26209890
[TBL] [Abstract][Full Text] [Related]
8. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
9. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
[TBL] [Abstract][Full Text] [Related]
10. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
Rockenstein E; Ubhi K; Doppler E; Novak P; Moessler H; Li B; Blanchard J; Grundke-Iqbal I; Iqbal K; Mante M; Adame A; Crews L; Masliah E
J Alzheimers Dis; 2011; 27(4):743-52. PubMed ID: 21860085
[TBL] [Abstract][Full Text] [Related]
11. Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice.
Hattori Y; Maki T; Saito S; Yamamoto Y; Nagatsuka K; Ihara M
J Alzheimers Dis; 2016 Apr; 52(3):1037-45. PubMed ID: 27079719
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
16. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
17. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
18. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
[TBL] [Abstract][Full Text] [Related]
19. Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice.
Mori T; Town T; Tan J; Yada N; Horikoshi Y; Yamamoto J; Shimoda T; Kamanaka Y; Tateishi N; Asano T
J Pharmacol Exp Ther; 2006 Aug; 318(2):571-8. PubMed ID: 16709678
[TBL] [Abstract][Full Text] [Related]
20. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
Herzig MC; Winkler DT; Burgermeister P; Pfeifer M; Kohler E; Schmidt SD; Danner S; Abramowski D; Stürchler-Pierrat C; Bürki K; van Duinen SG; Maat-Schieman ML; Staufenbiel M; Mathews PM; Jucker M
Nat Neurosci; 2004 Sep; 7(9):954-60. PubMed ID: 15311281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
